Novadip Biosciences closes a €10.4M funding round led by New Science Ventures. The funds will advance its NVD003 therapy through final clinical development stages.
Amount Raised
€10.4 Million
Round Type
Convertible Note
BelgiumBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Novadip Biosciences, a clinical biotech company, raised €10.4M in convertible financing. This funding round was led by New Science Ventures and aims to support the advancement of the company's NVD003 therapy. The capital will help complete a pivotal Phase 3 trial and prepare for regulatory submission. The company is targeting market authorization for NVD003 by 2028.
Quick answer
Novadip Biosciences raised €10.4 Million in a Convertible Note round, dated September 21, 2026. Investors: Invest.Bw, Fund+, Wallonie Entreprendre, Vives Fund, Orsa Tech, Sambrinvest, Noshaq and New Science Ventures. Novadip Biosciences is based in Belgium.
- How much did Novadip Biosciences raise?
- Novadip Biosciences raised €10.4 Million in a Convertible Note round on September 21, 2026.
- Who invested in Novadip Biosciences?
- Invest.Bw, Fund+, Wallonie Entreprendre, Vives Fund, Orsa Tech, Sambrinvest, Noshaq and New Science Ventures are named as investors in this round.
- What does Novadip Biosciences do?
- Novadip Biosciences is a biopharmaceutical company founded to design, develop and bring to the market innovative stem cell-based therapies for regenerative medicine.
- Where is Novadip Biosciences based and how big is it?
- Novadip Biosciences is based in Belgium. Fundz records about 58 employees.
- Who are the decision-makers at Novadip Biosciences?
- Fundz holds 2 contacts at Novadip Biosciences, including the Corporate Vice President Quality. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Novadip Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Alethio raised $90M (Series A) on November 5, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Tivic raised $85M (Series B) on October 27, 2026.
- Tivic raised $8.4M (Series B) on October 8, 2026.
- Rouge Therapeutics raised $58M (Series A) on October 6, 2026.
- Omnio raised $3.3M (Seed) on October 2, 2026.
Who to call at Novadip Biosciences, and when
A new round usually means Novadip Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Novadip Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novadip Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novadip Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novadip Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Novadip Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.